SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company headquartered in Foster City, California, that focuses on developing and commercializing therapies for oncology, infectious diseases, and cardiovascular disorders. The company's lead product, ZADAXIN, is utilized for treating hepatitis B and C, certain cancers, and enhancing immune function, with ongoing development for treating sepsis. In addition to ZADAXIN, SciClone offers a range of products including DC Bead, which is approved for liver cancer treatment in multiple countries, and ondansetron RapidFilm, used to manage nausea and vomiting related to chemotherapy and surgery. The company has established strategic partnerships to promote various products, such as Angiomax and Cleviprex. SciClone’s integrated platform emphasizes rapid growth in therapeutic areas with significant unmet medical needs, particularly in China.
Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs. Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The company develops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures. Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
NovaMed Pharmaceuticals
Acquisition in 2011
NovaMed Pharmaceuticals (诺凡麦医药) is a Chinese group based on virtual integration. It is focused on complete business functions such as sales and marketing, register, circulation, manufacture, and R&D. NovaMed Pharmaceuticals was founded by senior management personnel in transnational pharmaceutical companies. The founders are professionals with broad social networks and domestic market knowledge.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.